Healthy volunteers test generic cholesterol drug equivalence
NCT ID NCT07581028
First seen May 16, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This study tests whether a new cholesterol-lowering drug (AJU-C715) works the same as an existing one (C715R) in 60 healthy adults aged 19-59. Participants take a single dose of each drug in random order and have blood samples taken to measure drug levels. The goal is to check safety and bioequivalence, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
H+ Yangji Hospital
Seoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.